Is a Surprise Coming for Savara (SVRA) This Earnings ... Mar 11, 2020 Are Options Traders Betting on a Big Move in Savara (SVRA ... Investors in Savara Inc. SVRA need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 17, 2020 $5.00 Call had some of the highest implied volatility of all equity options today. SVRA - Savara News - Barchart.com
Find the latest Cassava Sciences, Inc. (SAVA) stock quote, history, news and other vital information to help you with your stock trading and investing. Savara (NASDAQ:SVRA) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Savara Inc. is a clinical-stage pharmaceutical company.
SVRA Stock Price and Chart — NASDAQ:SVRA — TradingView View live SAVARA INC chart to track its stock's price action. Find market predictions, SVRA financials and market news. is because the Jan 17, 2020 $5.00 Call had some of the highest implied volatility of all equity options today. Source Zacks Savara, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the
SVRA Stock Price, Forecast & News (Savara) | MarketBeat SVRA stock was acquired by a variety of institutional investors in the last quarter, including AXA, Acadian Asset Management LLC, Dupont Capital Management Corp, Geode Capital Management LLC, Intellectus Partners LLC, BlackRock Inc., SG Americas Securities LLC, and Bank of New York Mellon Corp. Company insiders that have bought Savara stock in SVRA Savara Inc. Stock Quote - FINVIZ.com - Stock Screener
We would like to show you a description here but the site won’t allow us. View Sabra Healthcare REIT Inc SBRA investment & stock information. Get the latest Sabra Healthcare REIT Inc SBRA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. SVRA: Mast Therapeutics, Inc. broker recommendations. Get the latest broker recommendations from Zacks Investment Research.